{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:19:03Z","timestamp":1792131543554,"version":"4.4.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-89384-4","type":"journal-article","created":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T04:40:44Z","timestamp":1738989644000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Assessment of serum survivin in women with placenta previa and accreta spectrum: a cross-sectional study"],"prefix":"10.1038","volume":"15","author":[{"given":"Nevin","family":"Yilmaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isil Turan","family":"Bakirci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Busra","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gokhan","family":"Bolluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra","family":"Can","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huri","family":"Dedeakayogullari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,8]]},"reference":[{"key":"89384_CR1","doi-asserted-by":"publisher","unstructured":"Obstetric Care Consensus No. Placenta Accreta Spectrum. Obstet. Gynecol. 7(6), https:\/\/doi.org\/10.1097\/AOG.0000000000002983 (2018).","DOI":"10.1097\/AOG.0000000000002983"},{"issue":"1","key":"89384_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ajog.2017.05.067","volume":"218","author":"E Jauniaux","year":"2018","unstructured":"Jauniaux, E., Collins, S. & Burton, G. J. Placenta accreta spectrum: Pathophysiology and evidence-based anatomy for prenatal ultrasound imaging. Am. J. Obstet. Gynecol. 218 (1), 75\u201387. https:\/\/doi.org\/10.1016\/j.ajog.2017.05.067 (2018).","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"89384_CR3","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.ogc.2015.01.014","volume":"42","author":"RM Silver","year":"2015","unstructured":"Silver, R. M. & Barbour, K. D. Placenta accreta spectrum: Accreta, increta, and percreta. Obstet. Gynecol. Clin. N. Am. 42 (2), 381\u2013402. https:\/\/doi.org\/10.1016\/j.ogc.2015.01.014 (2015).","journal-title":"Obstet. Gynecol. Clin. N. Am."},{"issue":"20","key":"89384_CR4","doi-asserted-by":"publisher","first-page":"9955","DOI":"10.26355\/eurrev_202310_34174","volume":"27","author":"G Balkas","year":"2023","unstructured":"Balkas, G. & Caglar, T. Elevated first-trimester PAPP-A is a marker in high-risk pregnancies with an increased risk of placenta accreta in predicting adverse outcomes. Eur. Rev. Med. Pharmacol. Sci. 27 (20), 9955\u20139961. https:\/\/doi.org\/10.26355\/eurrev_202310_34174 (2023).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"3","key":"89384_CR5","doi-asserted-by":"publisher","first-page":"433.e1","DOI":"10.1016\/j.ajog.2020.03.019","volume":"223","author":"SA Shainker","year":"2020","unstructured":"Shainker, S. A. et al. Placenta accreta spectrum: Biomarker discovery using plasma proteomics. Am. J. Obstet. Gynecol. 223 (3), 433.e1\u2013433.e14. https:\/\/doi.org\/10.1016\/j.ajog.2020.03.019 (2020).","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"89384_CR6","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1080\/01443615.2022.2068370","volume":"42","author":"F Okmen","year":"2022","unstructured":"Okmen, F. et al. The role of fetal fibronectin and plasminogen activator inhibitor 1 biomarkers in antenatal prediction of placenta accreta spectrum. J. Obstet. Gynaecol. 42 (6), 2008\u20132012. https:\/\/doi.org\/10.1080\/01443615.2022.2068370 (2022).","journal-title":"J. Obstet. Gynaecol."},{"issue":"12","key":"89384_CR7","first-page":"971","volume":"75","author":"W Uszy\u0144ski","year":"2004","unstructured":"Uszy\u0144ski, W. & Uszy\u0144ski, M. Placenta accreta: Epidemiology, molecular mechanism (hypothesis), and some clinical remarks. Ginekol. Pol. 75 (12), 971\u2013978 (2004).","journal-title":"Ginekol. Pol."},{"key":"89384_CR8","doi-asserted-by":"publisher","unstructured":"Fang, X. L. et al. Overview of role of survivin in cancer: Expression, regulation, functions, and its potential as a therapeutic target. J. Drug Target. 1\u201373. https:\/\/doi.org\/10.1080\/1061186X.2024.2309563 (2024).","DOI":"10.1080\/1061186X.2024.2309563"},{"issue":"4","key":"89384_CR9","doi-asserted-by":"publisher","first-page":"160","DOI":"10.15430\/JCP.2023.28.4.160","volume":"28","author":"K Turkekul","year":"2023","unstructured":"Turkekul, K. & Erdogan, S. Potent suppression of prostate cancer cell growth and eradication of cancer stem cells by CD44-targeted nanoliposome-quercetin nanoparticles. J. Cancer Prev. 28 (4), 160\u2013174. https:\/\/doi.org\/10.15430\/JCP.2023.28.4.160 (2023).","journal-title":"J. Cancer Prev."},{"issue":"1","key":"89384_CR10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1053\/plac.2002.0860","volume":"24","author":"A Shiozaki","year":"2003","unstructured":"Shiozaki, A. et al. Survivin inhibits apoptosis in cytotrophoblasts. Placenta 24 (1), 65\u201376. https:\/\/doi.org\/10.1053\/plac.2002.0860 (2003).","journal-title":"Placenta"},{"issue":"6","key":"89384_CR11","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/S0029-7844(01)01131-0","volume":"97","author":"R Lehner","year":"2001","unstructured":"Lehner, R., Bobak, J., Kim, N. W., Shroyer, A. L. & Shroyer, K. R. Localization of telomerase hTERT protein and survivin in placenta: Relation to placental development and hydatidiform mole. Obstet. Gynecol. 97 (6), 965\u2013970. https:\/\/doi.org\/10.1016\/S0029-7844(01)01131-0 (2001).","journal-title":"Obstet. Gynecol."},{"issue":"1","key":"89384_CR12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.placenta.2011.10.008","volume":"33","author":"CF Li","year":"2012","unstructured":"Li, C. F. et al. Reduced expression of survivin, the inhibitor of apoptosis protein, correlates with severity of preeclampsia. Placenta 33 (1), 47\u201351. https:\/\/doi.org\/10.1016\/j.placenta.2011.10.008 (2012).","journal-title":"Placenta"},{"issue":"6","key":"89384_CR13","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1080\/15384101.2016.1149273","volume":"15","author":"C Muschol-Steinmetz","year":"2016","unstructured":"Muschol-Steinmetz, C. et al. B-cell lymphoma 6 promotes proliferation and survival of trophoblastic cells. Cell. Cycle. 15 (6), 827\u2013839. https:\/\/doi.org\/10.1080\/15384101.2016.1149273 (2016).","journal-title":"Cell. Cycle"},{"issue":"3","key":"89384_CR14","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/ijgo.12333","volume":"140","author":"E Jauniaux","year":"2018","unstructured":"Jauniaux, E., Chantraine, F., Silver, R. M. & Langhoff-Roos, J. FIGO consensus guidelines on placenta accreta spectrum disorders: Epidemiology. Int. J. Gynaecol. Obstet. 140 (3), 265\u2013273. https:\/\/doi.org\/10.1002\/ijgo.12333 (2018).","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"1","key":"89384_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1600-0897.2007.00557.x","volume":"59","author":"S Fest","year":"2008","unstructured":"Fest, S. et al. Supporting the hypothesis of pregnancy as a tumor: Survivin is upregulated in normal pregnant mice and participates in human trophoblast proliferation. Am. J. Reprod. Immunol. 59 (1), 75\u201383. https:\/\/doi.org\/10.1111\/j.1600-0897.2007.00557.x (2008).","journal-title":"Am. J. Reprod. Immunol."},{"issue":"11","key":"89384_CR16","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.3390\/jpm13111563","volume":"13","author":"MC T\u00eernovanu","year":"2023","unstructured":"T\u00eernovanu, M. C. et al. Unexpected dramatic evolution of placenta increta: Case report and literature review. J. Personal. Med. 13 (11), 1563. https:\/\/doi.org\/10.3390\/jpm13111563 (2023).","journal-title":"J. Personal. Med."},{"issue":"3","key":"89384_CR17","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ogc.2022.02.004","volume":"49","author":"R Horgan","year":"2022","unstructured":"Horgan, R. & Abuhamad, A. Placenta accreta spectrum: Prenatal diagnosis and management. Obstet. Gynecol. Clin. N. Am. 49 (3), 423\u2013438. https:\/\/doi.org\/10.1016\/j.ogc.2022.02.004 (2022).","journal-title":"Obstet. Gynecol. Clin. N. Am."},{"key":"89384_CR18","doi-asserted-by":"publisher","first-page":"85","DOI":"10.21608\/bjas.2022.244597","volume":"7","author":"HH Sabry","year":"2022","unstructured":"Sabry, H. H. et al. Tissue expression of Survivin in hypertrophic scars before and after Intralesional Bleomycin. Benhav. J. Appl. Sci. 7, 85\u201389. https:\/\/doi.org\/10.21608\/bjas.2022.244597 (2022).","journal-title":"Benhav. J. Appl. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89384-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89384-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89384-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T04:40:46Z","timestamp":1738989646000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89384-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,8]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["89384"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-89384-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4951853\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,8]]},"assertion":[{"value":"21 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee for Human Studies of Kanuni Sultan Suleyman Training and Research Hospital (Approval number: KAEK\/2021.05.167).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all participants, and their privacy rights were strictly maintained throughout the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"4735"}}